Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Philippe Lanoix

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Antimicrobial Agents and Chemotherapy|February 20, 2020
Synergistic Activity of Clofazimine and Clarithromycin in an Aerosol Mouse Model of <i>Mycobacterium avium</i> InfectionJean-Philippe Lanoix, Cédric Joseph, François Peltier, et al.
Infectious Diseases Now|March 14, 2024
Measuring the prevalence of aspiration pneumonia in view of improving the relevance of antibiotic prescription of antibiotics: A retrospective, observational studyRodrigue Wankap, Lyasmine Azzoug, Florent Rossi, et al.
AIDS and Behavior|April 24, 2023
The Relationship Between Forgiveness and Health Outcomes Among People Living with HIV: A Cross-Sectional Study in FranceLoren L Toussaint, Sebastian Binyamin Skalski-Bednarz, Jean-Philippe Lanoix, et al.
Scandinavian Journal of Infectious Diseases|May 27, 2011
Neisseria meningitidis serogroup B meningitis relapse after five days of cefotaxime treatment: what went wrong?Jean-Philippe Lanoix, Celine Lecerf, Youssef El Samad, et al.
International Journal of Antimicrobial Agents|May 3, 2026
The need for systematic therapeutic drug monitoring of isoniazid in tuberculosis, a real-world studyMarine Chancel, Youssef Bennis, Sandra Bodeau, et al.
Antimicrobial Agents and Chemotherapy|November 18, 2015
Selective Inactivity of Pyrazinamide against Tuberculosis in C3HeB/FeJ Mice Is Best Explained by Neutral pH of CaseumJean-Philippe Lanoix, Thomas Ioerger, Aimee Ormond, et al.
The Journal of Infection|May 12, 2020
Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assaysBaptiste Demey, Nagib Daher, Catherine François, et al.
Nephrologie & Therapeutique|December 3, 2014
[Fanconi syndrome in a 22-year-old African patient]Morgane Wetzstein, Maïté Jauréguy, Jean-Philippe Lanoix, et al.
Infectious Diseases Now|August 13, 2025
Antibiotic susceptibility according to age of clinical strains from hospital respiratory samples: A nationwide studyAlain Putot, Elodie Couve-Deacon, Marie-Cécile Ploy, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 8, 2022
Number of initial symptoms is more related to long COVID-19 than acute severity of infection: a prospective cohort of hospitalized patientsAdrien Chan Sui Ko, Alexandre Candellier, Marie Mercier, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Antimicrobial Agents and Chemotherapy|February 20, 2020
Synergistic Activity of Clofazimine and Clarithromycin in an Aerosol Mouse Model of <i>Mycobacterium avium</i> InfectionJean-Philippe Lanoix, Cédric Joseph, François Peltier, et al.
Infectious Diseases Now|March 14, 2024
Measuring the prevalence of aspiration pneumonia in view of improving the relevance of antibiotic prescription of antibiotics: A retrospective, observational studyRodrigue Wankap, Lyasmine Azzoug, Florent Rossi, et al.
AIDS and Behavior|April 24, 2023
The Relationship Between Forgiveness and Health Outcomes Among People Living with HIV: A Cross-Sectional Study in FranceLoren L Toussaint, Sebastian Binyamin Skalski-Bednarz, Jean-Philippe Lanoix, et al.
Scandinavian Journal of Infectious Diseases|May 27, 2011
Neisseria meningitidis serogroup B meningitis relapse after five days of cefotaxime treatment: what went wrong?Jean-Philippe Lanoix, Celine Lecerf, Youssef El Samad, et al.
International Journal of Antimicrobial Agents|May 3, 2026
The need for systematic therapeutic drug monitoring of isoniazid in tuberculosis, a real-world studyMarine Chancel, Youssef Bennis, Sandra Bodeau, et al.
Antimicrobial Agents and Chemotherapy|November 18, 2015
Selective Inactivity of Pyrazinamide against Tuberculosis in C3HeB/FeJ Mice Is Best Explained by Neutral pH of CaseumJean-Philippe Lanoix, Thomas Ioerger, Aimee Ormond, et al.
The Journal of Infection|May 12, 2020
Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assaysBaptiste Demey, Nagib Daher, Catherine François, et al.
Nephrologie & Therapeutique|December 3, 2014
[Fanconi syndrome in a 22-year-old African patient]Morgane Wetzstein, Maïté Jauréguy, Jean-Philippe Lanoix, et al.
Infectious Diseases Now|August 13, 2025
Antibiotic susceptibility according to age of clinical strains from hospital respiratory samples: A nationwide studyAlain Putot, Elodie Couve-Deacon, Marie-Cécile Ploy, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 8, 2022
Number of initial symptoms is more related to long COVID-19 than acute severity of infection: a prospective cohort of hospitalized patientsAdrien Chan Sui Ko, Alexandre Candellier, Marie Mercier, et al.
Pageof 5